These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 28164651)

  • 1. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus.
    Vernal S; Julio TA; Alves FH; Turatti A; Donadi EA; Roselino AM
    An Bras Dermatol; 2024; 99(5):680-687. PubMed ID: 38851894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil.
    Hilario-Vargas J; Dasher DA; Li N; Aoki V; Hans-Filho G; dos Santos V; Qaqish BF; Rivitti EA; Diaz LA;
    J Invest Dermatol; 2006 Sep; 126(9):2044-8. PubMed ID: 16763546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin autoantibody profile in patients with pemphigus vulgaris.
    Oliveira ME; Culton DA; Prisayanh P; Qaqish BF; Diaz LA
    Br J Dermatol; 2013 Oct; 169(4):812-8. PubMed ID: 23725016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
    Russo I; Saponeri A; Michelotto A; Alaibac M
    In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
    Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
    J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
    Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
    J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Kamiya K; Aoyama Y; Yamasaki O; Kamata A; Yamagami J; Iwatsuki K; Tokura Y
    Br J Dermatol; 2016 Jan; 174(1):113-9. PubMed ID: 26294113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
    Barnadas MA; Rubiales MV; Gich I; Gelpí C
    Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
    Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
    J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin is an additional immunological target for pemphigus autoantibodies.
    Evangelista F; Dasher DA; Diaz LA; Prisayanh PS; Li N
    J Invest Dermatol; 2008 Jul; 128(7):1710-8. PubMed ID: 18219275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
    Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
    Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.